Skip to main navigation
AASLD Family of Websites:
The Liver Meeting
AASLD.org
AASLD Foundation
LiverLearning
Careers
Journals
Liver Fellow Network
HCV Guidelines
Menu
TLM Main Navigation
Claim CE Credits
For Industry
Why Exhibit
Reserve a Booth
Exhibitor Resources
Attend
Register Now
Registration Information
Exhibit Hall
Networking Events
Venue & Housing
Visa Letter
Awards & Honors Gala
Program
Schedule
Speakers
Special Programs
Academic Debate
Global Programming
Preliminary Guide
Register Now
Hyman J. Zimmerman Hepatotoxicity State of the Art: Systemic Therapy for Hepatocellular Carcinoma in 2025—Where Are We Now?
Nov
09
2025
Convention Center: Hall A (General Session), Concourse Level
11:00 AM - 11:30 AM
Live Streamed
Captured
World Class Speakers
Presenter
Laura M Kulik, MD
Northwestern Medical Faculty Foundation
Moderator
Tamar H Taddei, MD, MD, FAASLD
Yale University
Journey Maps
Liver Cancer
Presentations
7:23 PM - 7:23 PM
Nov
09
2025
Washington, D.C.
Introduction
Tamar H Taddei, MD, MD, FAASLD, Moderator
Liver Cancer
7:23 PM - 7:23 PM
Nov
09
2025
Washington, D.C.
Systemic Therapy for Hepatocellular Carcinoma in 2025: Where Are We Now?
Laura M Kulik, MD, Presenter
Liver Cancer